Larvol Delta - SOLARESAD1-To-Assess-the-Efficacy-and-Safety-of-SCD044-in-the-Treatment-of-Moderate-to-Severe-Atopic-Dermatitis

vibozilimod (SCD-044) - Sun Pharma

http://clinicaltrials.gov/ct2/show/NCT04684485

May 9, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next